Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in type 1 diabetes for prevention of cardiovascular and retinal complications
ACTRN12613001355763Phase 4Not yet recruiting
- Sponsor
- Pfizer
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of eplerenone in diabetes mellitus type 1 (T1D), sponsored by Pfizer. Planned start Jan 2014; status: not yet recruiting.
02
Drugs
eplerenone
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ACTRN12613001355763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001355763.